Literature DB >> 21844238

Proteomic analysis of Anaplasma phagocytophilum during infection of human myeloid cells identifies a protein that is pronouncedly upregulated on the infectious dense-cored cell.

Matthew J Troese1, Amandeep Kahlon, Stephanie A Ragland, Andrew K Ottens, Nore Ojogun, Kristina T Nelson, Naomi J Walker, Dori L Borjesson, Jason A Carlyon.   

Abstract

Anaplasma phagocytophilum is an obligate intracellular bacterium that invades neutrophils to cause the emerging infectious disease human granulocytic anaplasmosis. A. phagocytophilum undergoes a biphasic developmental cycle, transitioning between an infectious dense-cored cell (DC) and a noninfectious reticulate cell (RC). To gain insights into the organism's biology and pathogenesis during human myeloid cell infection, we conducted proteomic analyses on A. phagocytophilum organisms purified from HL-60 cells. A total of 324 proteins were unambiguously identified, thereby verifying 23.7% of the predicted A. phagocytophilum proteome. Fifty-three identified proteins had been previously annotated as hypothetical or conserved hypothetical. The second most abundant gene product, after the well-studied major surface protein 2 (P44), was the hitherto hypothetical protein APH_1235. APH_1235 homologs are found in other Anaplasma and Ehrlichia species but not in other bacteria. The aph_1235 RNA level is increased 70-fold in the DC form relative to that in the RC form. Transcriptional upregulation of and our ability to detect APH_1235 correlate with RC to DC transition, DC exit from host cells, and subsequent DC binding and entry during the next round of infection. Immunoelectron microscopy pronouncedly detects APH_1235 on DC organisms, while detection on RC bacteria minimally, at best, exceeds background. This work represents an extensive study of the A. phagocytophilum proteome, discerns the complement of proteins that is generated during survival within human myeloid cells, and identifies APH_1235 as the first known protein that is pronouncedly upregulated on the infectious DC form.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21844238      PMCID: PMC3257945          DOI: 10.1128/IAI.05658-11

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.609


  61 in total

1.  An improved procedure for the purification of protein fused with glutathione S-transferase.

Authors:  F Grieco; J M Hay; R Hull
Journal:  Biotechniques       Date:  1992-12       Impact factor: 1.993

2.  Ehrlichia chaffeensis expresses macrophage- and tick cell-specific 28-kilodalton outer membrane proteins.

Authors:  Vijayakrishna Singu; Haijie Liu; Chuanmin Cheng; Roman R Ganta
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

3.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

4.  Expression of major surface protein 2 variants with conserved T-cell epitopes in Anaplasma centrale vaccinates.

Authors:  Varda Shkap; Thea Molad; Kelly A Brayton; Wendy C Brown; Guy H Palmer
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

5.  Ultrastructural and antigenic characterization of a granulocytic ehrlichiosis agent directly isolated and stably cultivated from a patient in New York state.

Authors:  Y Rikihisa; N Zhi; G P Wormser; B Wen; H W Horowitz; K E Hechemy
Journal:  J Infect Dis       Date:  1997-01       Impact factor: 5.226

6.  Host cell-specific expression of a p44 epitope by the human granulocytic ehrlichiosis agent.

Authors:  S D Jauron; C M Nelson; V Fingerle; M D Ravyn; J L Goodman; R C Johnson; R Lobentanzer; B Wilske; U G Munderloh
Journal:  J Infect Dis       Date:  2001-11-13       Impact factor: 5.226

Review 7.  'Nothing is permanent but change'- antigenic variation in persistent bacterial pathogens.

Authors:  Guy H Palmer; Troy Bankhead; Sheila A Lukehart
Journal:  Cell Microbiol       Date:  2009-08-25       Impact factor: 3.715

8.  Infection of endothelial cells with Anaplasma marginale and A. phagocytophilum.

Authors:  Ulrike G Munderloh; Meghan J Lynch; Michael J Herron; Ann T Palmer; Timothy J Kurtti; Robert D Nelson; Jesse L Goodman
Journal:  Vet Microbiol       Date:  2004-06-10       Impact factor: 3.293

9.  Expression of multiple outer membrane protein sequence variants from a single genomic locus of Anaplasma phagocytophilum.

Authors:  A F Barbet; P F M Meeus; M Bélanger; M V Bowie; J Yi; A M Lundgren; A R Alleman; S J Wong; F K Chu; U G Munderloh; S D Jauron
Journal:  Infect Immun       Date:  2003-04       Impact factor: 3.441

10.  Global proteomic analysis of two tick-borne emerging zoonotic agents: anaplasma phagocytophilum and ehrlichia chaffeensis.

Authors:  Mingqun Lin; Takane Kikuchi; Heather M Brewer; Angela D Norbeck; Yasuko Rikihisa
Journal:  Front Microbiol       Date:  2011-02-17       Impact factor: 5.640

View more
  28 in total

1.  Orientia tsutsugamushi Ank9 is a multifunctional effector that utilizes a novel GRIP-like Golgi localization domain for Golgi-to-endoplasmic reticulum trafficking and interacts with host COPB2.

Authors:  Andrea R Beyer; Kyle G Rodino; Lauren VieBrock; Ryan S Green; Brittney K Tegels; Lee D Oliver; Richard T Marconi; Jason A Carlyon
Journal:  Cell Microbiol       Date:  2017-02-03       Impact factor: 3.715

Review 2.  The role of CD8 T lymphocytes in rickettsial infections.

Authors:  David H Walker; J Stephen Dumler
Journal:  Semin Immunopathol       Date:  2015-04-01       Impact factor: 9.623

Review 3.  Anaplasma phagocytophilum: deceptively simple or simply deceptive?

Authors:  Maiara S Severo; Kimberly D Stephens; Michail Kotsyfakis; Joao Hf Pedra
Journal:  Future Microbiol       Date:  2012-06       Impact factor: 3.165

4.  Anaplasma marginale Outer Membrane Protein A Is an Adhesin That Recognizes Sialylated and Fucosylated Glycans and Functionally Depends on an Essential Binding Domain.

Authors:  Kathryn S Hebert; David Seidman; Aminat T Oki; Jerilyn Izac; Sarvani Emani; Lee D Oliver; Daniel P Miller; Brittney K Tegels; Reiji Kannagi; Richard T Marconi; Jason A Carlyon
Journal:  Infect Immun       Date:  2017-02-23       Impact factor: 3.441

Review 5.  Anaplasma phagocytophilum--a widespread multi-host pathogen with highly adaptive strategies.

Authors:  Snorre Stuen; Erik G Granquist; Cornelia Silaghi
Journal:  Front Cell Infect Microbiol       Date:  2013-07-22       Impact factor: 5.293

6.  Postgenomic analyses reveal development of infectious Anaplasma phagocytophilum during transmission from ticks to mice.

Authors:  Juliana E Mastronunzio; Sebastian Kurscheid; Erol Fikrig
Journal:  J Bacteriol       Date:  2012-03-02       Impact factor: 3.476

7.  Anaplasma phagocytophilum surface protein AipA mediates invasion of mammalian host cells.

Authors:  David Seidman; Nore Ojogun; Naomi J Walker; Juliana Mastronunzio; Amandeep Kahlon; Kathryn S Hebert; Sophia Karandashova; Daniel P Miller; Brittney K Tegels; Richard T Marconi; Erol Fikrig; Dori L Borjesson; Jason A Carlyon
Journal:  Cell Microbiol       Date:  2014-04-03       Impact factor: 4.115

Review 8.  Epidemiological and Clinicopathological Features of Anaplasma phagocytophilum Infection in Dogs: A Systematic Review.

Authors:  Sarah El Hamiani Khatat; Sylvie Daminet; Luc Duchateau; Latifa Elhachimi; Malika Kachani; Hamid Sahibi
Journal:  Front Vet Sci       Date:  2021-06-23

9.  Anaplasma phagocytophilum Rab10-dependent parasitism of the trans-Golgi network is critical for completion of the infection cycle.

Authors:  Hilary K Truchan; Lauren VieBrock; Chelsea L Cockburn; Nore Ojogun; Brian P Griffin; Dayanjan S Wijesinghe; Charles E Chalfant; Jason A Carlyon
Journal:  Cell Microbiol       Date:  2015-10-07       Impact factor: 4.115

Review 10.  Breaking in and grabbing a meal: Anaplasma phagocytophilum cellular invasion, nutrient acquisition, and promising tools for their study.

Authors:  Hilary K Truchan; David Seidman; Jason A Carlyon
Journal:  Microbes Infect       Date:  2013-10-18       Impact factor: 9.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.